Guardian Pharmacy Services, Inc.
NYSE:GRDNMedical - Distribution
+$0.17 today
- Market cap
- $3.09B
- Beta
- 0.08
- P/E (TTM)
- 52.0
- EPS (TTM)
- $0.84
Volume 0.45M
Average 0.48M
GRDN Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Guardian Pharmacy Services, Inc.NYSE: GRDN
Net Receivables · Q2 FY2026 · quarter ended Jun 2026
Net receivables rises 10.2% from a year ago
Net receivables stood at $103.77M at the end of Q2 FY2026, up 10.2% from a year earlier and down 7.1% from the prior quarter. Over 3 fiscal years it compounded at +14.4% a year.
Context
- Net receivables amounted to 23.4% of total assets at the end of Q2 FY2026, down 3.0 pp from a year earlier.
- Net receivables increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net receivables keeps rising in the next quarterly balance sheet after a +10.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 101.61M USD
- Year-over-year change
- +4.6%
- 4-year CAGR
- +16.5%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 101.61M | +4.6% |
| FY2024 | 2024-12-31 | 97.15M | +25.7% |
| FY2023 | 2023-12-31 | 77.26M | +13.9% |
| FY2022 | 2022-12-31 | 67.83M | +22.8% |
| FY2021 | 2021-12-31 | 55.25M | — |
Net Receivables vs competitors
How GRDN compares with its peers on the latest reported figures
- GRDN's Jun 2026 net receivables of $103.77M is the 4th highest of the 11 companies compared; the peer median is $64.48M.
- Its year-over-year change of +10.2% is the 7th highest of 10, against a peer median of +21.6%.
- Net receivables amounts to 23.4% of total assets for GRDN, versus a peer median of 6.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $486.7M | +11.4% | -10.7% | 8.6% | |
| Sep 2026 | $240.29M | +2.3% | -6.5% | 11.2% | |
| Sep 2026 | $129.75M | -2.0% | +11.5% | 6.3% | |
GRDNGuardian Pharmacy Services, Inc. | Jun 2026 | $103.77M | +10.2% | +14.4% | 23.4% |
| Mar 2026 | $96.39M | +21.6% | +76.2% | 19.8% | |
| Sep 2026 | $70.19M | +22.5% | +16.8% | 6.3% | |
| Sep 2026 | $58.76M | -39.2% | -7.5% | 5.5% | |
| Jun 2026 | $57.08M | +283.9% | +102.0% | 7.4% | |
| Mar 2026 | $42.46M | +660.3% | +109.4% | 4.1% | |
| Jun 2026 | $31.71M | +375.0% | +98.2% | 4.3% | |
| Sep 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding GRDN) | $64.48M | +21.6% | +16.8% | 6.3% | |
Competitors are the stored peer set for GRDN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 15.01M | 607K | 752K | 4.66M | 65.62M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 55.25M | 67.83M | 77.26M | 97.15M | 101.61M |
| Inventory | 33.09M | 41.44M | 36.73M | 40.55M | 43.36M |
| Other Current Assets | 8.52M | 10.12M | 14.86M | 9.62M | 11.04M |
| Total Current Assets | 111.87M | 120M | 129.6M | 151.99M | 221.63M |
| Property, Plant & Equipment (Net) | 51.72M | 65.19M | 73.18M | 78.96M | 90.17M |
| Goodwill | 54.63M | 56.05M | 56.05M | 69.3M | 79.74M |
| Intangible Assets | 17.09M | 14.44M | 11.98M | 14.91M | 18.48M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 5.27M | 2.2M |
| Other Non-current Assets | 529K | 435K | 358K | 383K | 436K |
| Total Non-current Assets | 123.98M | 136.12M | 141.56M | 168.83M | 191.02M |
| Total Assets | 235.85M | 256.11M | 271.17M | 320.81M | 412.66M |
| Account Payables | 64.62M | 78.1M | 85.6M | 102.42M | 116.21M |
| Short-term Debt | 3.71M | 7.96M | 12.98M | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 20.42M | 3.62M | 12.33M | 34.87M | 37.35M |
| Total Current Liabilities | 111.54M | 112.01M | 138.02M | 144.12M | 160.7M |
| Long-term Debt | 26.99M | 22.97M | 18.99M | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 27.88M | 21.54M | 27.26M | 3.42M | 4.04M |
| Total Non-current Liabilities | 70.99M | 68.18M | 73.29M | 26.71M | 34.03M |
| Total Liabilities | 182.53M | 180.18M | 211.31M | 170.83M | 194.73M |
| Common Stock | 24.11M | 42.73M | 28.21M | 63K | 63K |
| Retained Earnings | 0 | 0 | 0 | 17.12M | 66.34M |
| Accumulated OCI | (185K) | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 29.39M | 33.2M | 31.65M | 7.31M | 12.17M |
| Total Equity | 53.32M | 75.93M | 59.86M | 149.98M | 217.92M |
| Total Debt | 55.04M | 62.98M | 69.15M | 30.13M | 37.14M |
| Net Debt | 40.03M | 62.38M | 68.4M | 25.47M | (28.48M) |
Guardian Pharmacy Services, Inc.
NYSE:GRDN
Intrinsic Alpha fair value
Locked
Current Price
$48.84
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.